Theralase Technologies Inc.
TLTFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $48,839 | $47,327 | $46,346 | $62,143 |
| - Cash | $81 | $46 | $132 | $269 |
| + Debt | $320 | $245 | $270 | $294 |
| Enterprise Value | $49,077 | $47,525 | $46,483 | $62,168 |
| Revenue | $280 | $220 | $91 | $410 |
| % Growth | 27.3% | 141% | -77.8% | – |
| Gross Profit | $159 | $119 | $13 | $263 |
| % Margin | 56.8% | 54% | 14.6% | 64.1% |
| EBITDA | -$942 | -$886 | -$1,401 | -$844 |
| % Margin | -336.7% | -403.1% | -1,536.5% | -205.7% |
| Net Income | -$1,012 | -$952 | -$1,471 | -$918 |
| % Margin | -361.9% | -433.2% | -1,613.4% | -223.7% |
| EPS Diluted | -0.004 | -0.004 | -0.006 | -0.004 |
| % Growth | -5.3% | 36.7% | -57.9% | – |
| Operating Cash Flow | -$687 | -$1,023 | -$348 | -$457 |
| Capital Expenditures | -$15 | -$11 | -$65 | -$7 |
| Free Cash Flow | -$702 | -$1,034 | -$412 | -$464 |